Stilla at the 12th World Clinical Biomarkers & CDx Summit

• Boston
• US

Join us at the 12th World Clinical Biomarkers & CDx Summit in Boston this September 26-29th. Philippe Mourere, Stilla President & CEO, will present: Getting de-centralized testing into routine clinical oncology using high-performance genetic multiplexing with digital PCR on Thursday, September 29th at 2:55pm

https://world-cdx.com/